Cellular and vaccination-based immunotherapy of acute myeloid leukaemia
Approximately 50% of Acute Myeloid Leukaemia (AML) patients relapse within 5 years of diagnosis. Allogeneic haematopoietic stem cell transplantation (HSCT) has curative potential, partly mediated by a Graft-versus-Leukaemia (GvL) effect. GvL activity may be boosted by donor lymphocyte infusions (DLI...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.677025 |